I agree that this site is using cookies. You can find further informations here.
X
van der Noort, Vincent
240  results:
Search for persons X
?
1

Cemiplimab in locally advanced or metastatic cutaneous squa..:

Verkerk, Karlijn ; Geurts, Birgit S. ; Zeverijn, Laurien J....
The Lancet Regional Health - Europe.  39 (2024)  - p. 100875 , 2024
Link: https://doi.org/10.1016/..
 
?
2

The optimal treatment for patients with stage I non-small c..:

de Ruiter, Julianne Cynthia ; van der Noort, Vincent ; van Diessen, Judi Nani Annet...
Lung Cancer.  191 (2024)  - p. 107792 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Trastuzumab plus pertuzumab for HER2-amplified advanced col..:

Spiekman, Ilse A.C. ; Zeverijn, Laurien J. ; Geurts, Birgit S....
European Journal of Cancer.  202 (2024)  - p. 113988 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Blood platelet RNA profiles do not enable for nivolumab res..:

Muller, Mirte ; Best, Myron G. ; van der Noort, Vincent...
Tumor Biology.  46 (2024)  s1 - p. S327-S340 , 2024
Link: https://doi.org/10.3233/..
 
?
5

Penile cancer care in the Netherlands: increased incidence,..:

Vreeburg, Manon T.A. ; de Vries, Hielke‐Martijn ; van der Noort, Vincent...
BJU International.  133 (2024)  5 - p. 596-603 , 2024
Link: https://doi.org/10.1111/..
 
?
6

Limited clinical activity of palbociclib and ribociclib mon..:

Zeverijn, Laurien J. ; Looze, Eleonora J. ; Thavaneswaran, Subotheni...
International Journal of Cancer.  153 (2023)  7 - p. 1413-1422 , 2023
Link: https://doi.org/10.1002/..
 
?
7

Sentinel Node Procedure to Select Clinically Localized Pros..:

de Barros, Hilda A. ; Duin, Jan J. ; Mulder, Daan...
European Urology Open Science.  49 (2023)  - p. 80-89 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Efficacy and Safety of Panitumumab in Patients With RAF/RAS..:

Spiekman, Ilse A C ; Geurts, Birgit S ; Zeverijn, Laurien J...
The Oncologist.  29 (2023)  5 - p. 431-440 , 2023
Link: https://doi.org/10.1093/..
 
?
9

Risk factors for cognitive impairment in radically treated ..:

Zeng, Haiyan ; Hendriks, Lizza E.L. ; Witlox, Willem J.A....
Radiotherapy and Oncology.  183 (2023)  - p. 109627 , 2023
Link: https://doi.org/10.1016/..
 
?
10

External validation of the Rotterdam Prostate Cancer Risk C..:

Hagens, Marinus J. ; Stelwagen, Piter J. ; Veerman, Hans...
Tijdschrift voor Urologie.  13 (2023)  5 - p. 98-105 , 2023
Link: https://doi.org/10.1007/..
 
?
11

Pembrolizumab plus lenvatinib in second-line and third-line..:

Douma, Li-Anne H ; Lalezari, Ferry ; van der Noort, Vincent...
The Lancet Oncology.  24 (2023)  11 - p. 1219-1228 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Efficacy, safety and biomarker analysis of durvalumab in pa..:

Geurts, Birgit S. ; Battaglia, Thomas W. ; van Berge Henegouwen, J. Maxime...
BMC Cancer.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
13

A Targeted Discharge Pathway to Reduce Hospital Readmission..:

Buma, Sannine ; van Klinken, Merel ; van der Noort, Vincent
Seminars in Oncology Nursing.  39 (2023)  6 - p. 151506 , 2023
Link: https://doi.org/10.1016/..
 
?
14

A Prospective Study of Chemoradiotherapy as Primary Treatme..:

Ottenhof, Sarah Rosanne ; de Vries, Hielke Martijn ; Doodeman, Barry...
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  1 - p. 139-147 , 2023
Link: https://doi.org/10.1016/..
 
?
15

PD-1T TILs as a Predictive Biomarker for Clinical Benefit t..:

Hummelink, Karlijn ; van der Noort, Vincent ; Muller, Mirte...
Clinical Cancer Research.  28 (2022)  22 - p. 4893-4906 , 2022
Link: https://doi.org/10.1158/..
 
1-15